Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 7/20 | 0.55 |
| ▸ | OPRM1 | P35372 | 6/20 | 0.55 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.55 |
| ▸ | HSD17B1 | P14061 | 5/20 | 0.48 |
| ▸ | HSD17B2 | P37059 | 5/20 | 0.48 |
| ▸ | DRD2 | P14416 | 3/20 | 0.45 |
| ▸ | DRD3 | P35462 | 3/20 | 0.45 |
| ▸ | DRD1 | P21728 | 1/20 | 0.45 |
| ▸ | DRD4 | P21917 | 1/20 | 0.45 |
| ▸ | DRD5 | P21918 | 1/20 | 0.45 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.44 |
| ▸ | MEP1A | Q16819 | 1/20 | 0.43 |
| ▸ | MEP1B | Q16820 | 1/20 | 0.43 |
| ▸ | GYS1 | P13807 | 1/20 | 0.43 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17714023 | 0.97 | OPRK1 (0.60) | OPRK1OPRM1OPRD1HSD17B1HSD17B2 | |
| SCHEMBL8423257 | 0.95 | OPRK1 (0.54) | OPRK1OPRM1OPRD1HSD17B1HSD17B2 | |
| SCHEMBL8421332 | 0.95 | OPRK1 (0.56) | OPRK1OPRM1OPRD1HSD17B1HSD17B2 | |
| SCHEMBL7759713 | 0.84 | MEP1B (0.51) | MEP1AMEP1BGYS1 | |
| SCHEMBL2799777 | 0.82 | TDP1 (0.52) | OPRK1OPRM1OPRD1DRD3DRD1 | |
| SCHEMBL7562335 | 0.82 | AKR1B1 (0.46) | DRD3DRD1MEP1AMEP1BGYS1 | |
| SCHEMBL7799512 | 0.81 | MEP1B (0.62) | MEP1AMEP1B | |
| SCHEMBL2284795 | 0.80 | TDP1 (0.56) | DRD3DRD1MEP1B | |
| SCHEMBL7564337 | 0.79 | TDP1 (0.58) | DRD3DRD1 | |
| SCHEMBL8425195 | 0.78 | TSHR (0.51) | DRD3DRD1CTBP2MEP1AMEP1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1282394-B1 | USE OF N,N'-DIBENZYL ETHYLENE DIAMINE N,N'-DIACETIC ACID DERIVATIVES AS ANTI-POLLUTION AGENT | OREAL (FR) | 2004-09-29 | — | — | EP | claimed |
| US-20040039059-A1 | Use of n,n' -dibenzyl ethylene diamine-n, n'- diacetic acid derivatives as anti-pollution agent | L'OREAL (FR) | 2004-02-26 | — | — | US | claimed |
| US-5834518-A | FOR APPLICATION TO SKIN | L'OREAL (FR) | 1998-11-10 | — | — | US | claimed |
| US-20040039059-A1 | Use of n,n' -dibenzyl ethylene diamine-n, n'- diacetic acid derivatives as anti-pollution agent | L'OREAL (FR) | 2004-02-26 | — | — | US | disclosed |
| US-6005006-A | BLEACHING AND DEPIGMENTING COMPOUNDS FOR SKIN | L'OREAL (FR) | 1999-12-21 | — | — | US | disclosed |
| US-5834518-A | FOR APPLICATION TO SKIN | L'OREAL (FR) | 1998-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040039059-A1 | Use of n,n' -dibenzyl ethylene diamine-n, n'- diacetic acid derivatives as anti-pollution agent | DDT, NAA15, NDC1 | OPRK1 3715/4885OPRM1 3552/4885OPRD1 1642/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.